Helen Heslop
Directeur/Bestuurslid bij The Leukemia & Lymphoma Society, Inc.
Profiel
Helen E.
Heslop is the founder of AlloVir, Inc. (founded in 2013) and Tikva Allocell Pte Ltd.
(founded in 2023).
Currently, Dr. Heslop holds the position of Director at The Leukemia & Lymphoma Society, Inc. since 2023.
Additionally, Dr. Heslop is a Director at the Center For Cell & Gene Therapy and Deputy Director at the Dan L.
Duncan Comprehensive Cancer Center.
Actieve functies van Helen Heslop
| Bedrijven | Functie | Begin |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Directeur/Bestuurslid | 01-07-2023 |
| Dan L. Duncan Comprehensive Cancer Center | Corporate Officer/Principal | - |
| Center For Cell & Gene Therapy | Directeur/Bestuurslid | - |
Eerdere bekende functies van Helen Heslop
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLOVIR, INC. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALLOVIR, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
| Dan L. Duncan Comprehensive Cancer Center | |
| Center For Cell & Gene Therapy |
